| 1Maleic acid |
|---|
| 2Fumaric acid |
| 3Phenylephrine |
| 4Acetaminophen |
| 5Pheniramine |
| 6Doxylamine |
| 7Pyrilamine |
| 8Chlorpheniramine |
| 9Guaifenesin |
| 10Brompheniramine |
| 11Acetylsalicylic acid |
| 124-Nitrophenol |
| 13Impurity |
| 14Dextromethorphan |
| 15Diphenhydramine |
| 16Clemastine |
| 17Ibuprofen |
search
Applications
Cold medicine compounds on Kinetex 2.6 µm EVO C18
23036
Separation Mode: Reversed Phase
Reversed Phase
EVO C18
HPLC
Antipruritics,Antiparkinson Agents,Anti-Inflammatory Agents, Non-Steroidal,Antiemetics,Anti-Allergic Agents,Anesthetics, Local,Vasoconstrictor Agents,Sympathomimetics,Platelet Aggregation Inhibitors,Analgesics, Opioid
Pharmaceutical/Biopharmaceutical
Pharmaceutical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 23036)
Column: |
Brand Name: Kinetex |
Part No: |
Phase Name: EVO C18 |
Sample Note: Forced degradation protocol:
Reconstitute 1 mg of cefaclor neat standard with 1.0 mL of 1 M HCl. Heat the solution at 60 ºC for 6 hours then neutralize with 1.0 mL of 1 M NaOH. Refrigerate until ready to inject. |
Similar Applications
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.